Literature DB >> 25949082

Four petals evisceration for atrophia bulbi.

Molham A Elbakary1.   

Abstract

PURPOSE: To study the use of four petals evisceration in atrophia bulbi to allow insertion of large orbital implant.
MATERIALS AND METHODS: An interventional case series. All cases were atrophia bulbi. The axial lengths (AL) of atrophic and contralateral normal eye were measured. It was planned to use implant 3 mm smaller than AL of the contralateral normal eye. Four petals evisceration was used in all cases.
RESULTS: Twenty cases were included. The mean age was 27.08 ± 16.07 years. The mean axial length (AL) of atrophic eyes was 16.97 ± 1.42 mm. In 75% of cases, the planned implant was inserted. In all cases, the implant diameter was larger than AL of atrophic eye by a mean of 2.57 ± 0.64 mm. The AL of atrophic eye did not affect the implant size. The mean follow-up period was 22.4 ± 10.1 months. Implant exposure was not recorded in any case. Volume deficiency was recorded in 2 cases (10%).
CONCLUSIONS: Four petals evisceration facilitated the use of suitable sized implant in atrophia bulbi with minimal complications.

Entities:  

Keywords:  Atrophia Bulbi; Evisceration; Scleral Modification

Mesh:

Year:  2015        PMID: 25949082      PMCID: PMC4411621          DOI: 10.4103/0974-9233.150645

Source DB:  PubMed          Journal:  Middle East Afr J Ophthalmol        ISSN: 0974-9233


  23 in total

1.  Volumetric determination of enucleation implant size.

Authors:  P L Custer; K M Trinkaus
Journal:  Am J Ophthalmol       Date:  1999-10       Impact factor: 5.258

2.  Evisceration with scleral modification.

Authors:  G G Massry; J B Holds
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2001-01       Impact factor: 1.746

3.  Evisceration and enucleation: a national survey of practice patterns in the United States.

Authors:  Ruchi D Shah; Ramesh M Singa; Vinay K Aakalu; Pete Setabutr
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2012 Sep-Oct

4.  Implant extrusion in eviscerations.

Authors:  C L Zolli
Journal:  Ann Ophthalmol       Date:  1988-04

5.  The anophthalmic socket.

Authors:  D B Soll
Journal:  Ophthalmology       Date:  1982-05       Impact factor: 12.079

6.  A modified evisceration technique with scleral quadrisection and porous polyethylene implantation.

Authors:  Danping Huang; Yangyang Yu; Rong Lu; Huasheng Yang; Jianhao Cai
Journal:  Am J Ophthalmol       Date:  2009-02-10       Impact factor: 5.258

7.  The porous polyethylene (Medpor) spherical orbital implant: a retrospective study of 136 cases.

Authors:  Sean M Blaydon; Todd R Shepler; Russell W Neuhaus; William L White; John W Shore
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2003-09       Impact factor: 1.746

8.  Choice of procedure. Enucleation, evisceration, or prosthetic fitting over globes.

Authors:  R K Dortzbach; J J Woog
Journal:  Ophthalmology       Date:  1985-09       Impact factor: 12.079

9.  A simple algorithm for selection of implant size for enucleation and evisceration: a prospective study.

Authors:  Sara A Kaltreider; Mark J Lucarelli
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2002-09       Impact factor: 1.746

10.  Evisceration with four anterior relaxing incisions and circumferential posterior sclerotomies with porous polyethylene orbital implants: an 8-year study.

Authors:  Kyun-Hyung Kim; Hwa Lee; Minsoo Park; Mi chung Chi; Jongmi Lee; Sehyun Baek
Journal:  Acta Ophthalmol       Date:  2010-01-14       Impact factor: 3.761

View more
  2 in total

1.  Risk factors for orbital implant exposure after evisceration: A case control study of 93 patients.

Authors:  Roshmi Gupta; Parvathi Hari; Bhawna Khurana; Anjali Kiran
Journal:  Indian J Ophthalmol       Date:  2019-07       Impact factor: 1.848

2.  Enucleation and evisceration at a tertiary care hospital in a developing country.

Authors:  Osama H Ababneh; Eman A AboTaleb; Mohammad A Abu Ameerh; Yacoub A Yousef
Journal:  BMC Ophthalmol       Date:  2015-09-11       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.